Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238

Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1993 • 1,563 citations

Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.

1994 • 329 citations

Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization

1995 • 286 citations

Somatostatin analogs in the diagnosis and treatment of cancer

2002 • 218 citations

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

1998 • 210 citations

Mechanisms of Antineoplastic Action of Somatostatin Analogs

1998 • 166 citations

Somatostatin receptor subtypes sst1, sst2, sst3 and sst5expression in human pituitary, gastroentero-pancreatic and mammary tumors

1997 • 148 citations

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin

1998 • 143 citations

Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: Relationship to egf receptors

1990 • 142 citations

Human breast cancer cell line xenografts as models of breast cancer — The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines

1996 • 128 citations

Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels

1996 • 120 citations

Evaluation of Receptors for Somatostatin in Various Tumors Using Different Analogs*

1990 • 113 citations

Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.

1998 • 111 citations

Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues

1995 • 97 citations

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin.

1996 • 92 citations

Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: Evidence for SSTR2 heterogeneity

1994 • 91 citations

Growth Inhibition of Human Ovarian Cancers by Cytotoxic Analogues of Luteinizing Hormone-Releasing Hormone

1997 • 75 citations

Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses.

1998 • 57 citations

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells

1992 • 47 citations

Internalization and Subcellular Distribution of Radiolabeled Somatostatin-28 in Mouse Anterior Pituitary Tumor Cells*

1986 • 41 citations

Analysis of somatostatin receptor subtype mRNA expression in human breast cancer

1997 • 40 citations

Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination

1992 • 27 citations

A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumours

1993 • 24 citations

Intemalisation of Isotope-Coupled Somatostatin Analogues

1996 • 24 citations

Somatostatin Receptor Manipulation

1996 • 19 citations